Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma
NCT03738111
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Sponsor's commercial decision
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
TG02 Citrate
Sponsor
Lee's Pharmaceutical Limited
Collaborators
[object Object]